Verastem (VSTM) Convertible Debt (2018 - 2022)
Verastem's (VSTM) quarterly Convertible Debt came in at $268000.0 in Q3 2022, up 10.29% year-on-year from $243000.0 in Q3 2021, and up 2.29% quarter-over-quarter from $262000.0 in Q2 2022.
Verastem (VSTM) Convertible Debt (2018 - 2022) Analysis & Trends
Verastem's Convertible Debt history runs 5 years deep, the most recent figure standing at $268000.0 for Q3 2022.
- On a quarterly basis, Convertible Debt rose 10.29% year-over-year to $268000.0 in Q3 2022; TTM through Sep 2022 was $268000.0, a 10.29% increase from a year earlier, with the FY2021 full-year figure at $249000.0, down 98.69% from the prior year.
- Convertible Debt advanced to $268000.0 in Q3 2022 per VSTM's latest filing, from $262000.0 in the prior quarter.
- Across five years, Convertible Debt topped out at $101.2 million in Q3 2019 and bottomed at $243000.0 in Q3 2021.
- The 5-year median for Convertible Debt is $20.1 million (2020), against an average of $36.4 million.
- Across the five-year window, Convertible Debt tumbled 98.83% in 2021 and grew 10.29% in 2022, its largest moves.
- Year by year, Convertible Debt stood at $95.2 million in 2018, then declined by 28.01% to $68.6 million in 2019, then slumped by 72.21% to $19.1 million in 2020, then slumped by 98.69% to $249000.0 in 2021, then climbed by 7.63% to $268000.0 in 2022.
- Per Business Quant, the three latest VSTM Convertible Debt figures stand at $268000.0 (Q3 2022), $262000.0 (Q2 2022), and $255000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 268,000.00 |
| Jun 30, 2022 | 262,000.00 |
| Mar 31, 2022 | 255,000.00 |
| Dec 31, 2021 | 249,000.00 |
| Sep 30, 2021 | 243,000.00 |
| Jun 30, 2021 | 20.33 Mn |
| Mar 31, 2021 | 19.67 Mn |
| Dec 31, 2020 | 19.05 Mn |
| Sep 30, 2020 | 20.84 Mn |
| Jun 30, 2020 | 20.38 Mn |
| Mar 31, 2020 | 19.94 Mn |
| Dec 31, 2019 | 68.56 Mn |
| Sep 30, 2019 | 101.25 Mn |
| Jun 30, 2019 | 99.16 Mn |
| Mar 31, 2019 | 97.16 Mn |
| Dec 31, 2018 | 95.23 Mn |